Similar articles

• [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].

  Baumgart P. Baumgart P. MMW Fortschr Med. 2008 Jan 17;150(1-2):52-3. MMW Fortschr Med. 2008. PMID: 18300647 German. No abstract available.
• [Kidney protection leads to heart protection, too].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2006 Aug 17;148(33-34):57. MMW Fortschr Med. 2006. PMID: 16981393 German. No abstract available.
• [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].

  Baumgart P. Baumgart P. MMW Fortschr Med. 2006 Mar 16;148(11):57, 59-60. MMW Fortschr Med. 2006. PMID: 16612965 German. No abstract available.
• Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.

  Devereux RB, Dahlöf B. Devereux RB, et al. Curr Med Res Opin. 2007 Feb;23(2):443-57. doi: 10.1185/030079906X167435. Curr Med Res Opin. 2007. PMID: 17288698 Review.
• Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.

  Abe M, Okada K, Matsumoto K. Abe M, et al. Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1285-303. doi: 10.1517/17425250903282799. Expert Opin Drug Metab Toxicol. 2009. PMID: 19761411 Review.